AR018252A1 - Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral. - Google Patents
Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral.Info
- Publication number
- AR018252A1 AR018252A1 ARP980104098A ARP980104098A AR018252A1 AR 018252 A1 AR018252 A1 AR 018252A1 AR P980104098 A ARP980104098 A AR P980104098A AR P980104098 A ARP980104098 A AR P980104098A AR 018252 A1 AR018252 A1 AR 018252A1
- Authority
- AR
- Argentina
- Prior art keywords
- dosage form
- solid particles
- pharmaceutical dosage
- particles suitable
- oral supply
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Dispersiones de partículas solidas de agentes farmacéuticos en una matriz de un polímero soluble en agua que exhiben buena disolucion acuosay aumento de biodisponibilidad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5619597P | 1997-08-21 | 1997-08-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018252A1 true AR018252A1 (es) | 2001-11-14 |
Family
ID=22002810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980104098A AR018252A1 (es) | 1997-08-21 | 1998-08-19 | Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20010048946A1 (es) |
EP (1) | EP1011640A1 (es) |
JP (1) | JP2001515029A (es) |
KR (1) | KR20010023085A (es) |
AR (1) | AR018252A1 (es) |
AU (1) | AU8600098A (es) |
BR (1) | BR9811972A (es) |
CA (1) | CA2292586C (es) |
CO (1) | CO4960652A1 (es) |
GT (1) | GT199800136A (es) |
HN (1) | HN1998000115A (es) |
NZ (1) | NZ502869A (es) |
PA (1) | PA8458101A1 (es) |
PE (1) | PE109599A1 (es) |
SV (1) | SV1998000104A (es) |
WO (1) | WO1999008660A1 (es) |
ZA (1) | ZA987551B (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992018106A1 (en) * | 1991-04-16 | 1992-10-29 | Nippon Shinyaku Co., Ltd. | Method of manufacturing solid dispersion |
JPH06511291A (ja) * | 1991-08-02 | 1994-12-15 | ウィルコム タフティング ピーティーワイ リミテッド | 房付け方法及び房付けシステム |
US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
MXPA02006324A (es) | 1999-12-23 | 2002-12-13 | Pfizer Prod Inc | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco. |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
DE60143704D1 (de) * | 2000-09-25 | 2011-02-03 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer medizinischen festen dispersion |
CA2363902C (en) * | 2000-12-07 | 2005-07-26 | Warner-Lambert Company | Process and system for controlled-release drug delivery |
EP1404300B1 (en) | 2001-06-22 | 2009-09-30 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
GB0127805D0 (en) * | 2001-11-20 | 2002-01-09 | Smithkline Beecham Plc | Pharmaceutical composition |
EP1469832B2 (en) | 2002-02-01 | 2016-10-26 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
GB0205253D0 (en) * | 2002-03-06 | 2002-04-17 | Univ Gent | Immediate release pharmaceutical granule compositions and a continuous process for making them |
CA2496441C (en) * | 2002-08-12 | 2010-03-16 | Pfizer Products Inc. | Pharmaceutical compositions of semi-ordered drugs and polymers |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US20050100608A1 (en) * | 2003-02-21 | 2005-05-12 | Watson Pharmaceuticals, Inc. | Testosterone oral dosage formulations and associated methods |
US8273371B2 (en) * | 2003-06-27 | 2012-09-25 | Johan Adriaan Martens | Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
GB0315012D0 (en) * | 2003-06-27 | 2003-07-30 | Leuven K U Res & Dev | Zeotiles |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2531564C (en) * | 2003-07-18 | 2016-01-19 | Santarus, Inc. | Pharmaceutical composition for inhibiting acid secretion |
WO2005011635A2 (en) | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
PL1691787T3 (pl) * | 2003-12-04 | 2008-11-28 | Pfizer Prod Inc | Sposób wytwarzania farmaceutycznych systemów wielocząstkowych |
EP1718303A4 (en) * | 2004-02-10 | 2010-09-01 | Santarus Inc | COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG |
US20050202079A1 (en) * | 2004-03-15 | 2005-09-15 | Mylan Pharmaceuticals Inc. | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2598204C (en) | 2004-11-09 | 2015-01-13 | Board Of Regents, The University Of Texas System | Stabilized hme composition with small drug particles |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
ES2401992T3 (es) * | 2004-12-30 | 2013-04-26 | Pierre Fabre Medicament | Dispersión sólida estable de un derviado de alcaloide de vinca y procedimiento para su preparación |
FR2880274B1 (fr) * | 2004-12-30 | 2007-04-13 | Pierre Fabre Medicament Sa | Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication |
US20060147518A1 (en) * | 2004-12-30 | 2006-07-06 | Pierre Fabre Medicament | Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it |
NZ562304A (en) * | 2005-05-10 | 2010-06-25 | Novartis Ag | Extrusion process for making compositions with poorly compressible therapeutic compounds e.g. metformin hydrochloride |
GB0612695D0 (en) * | 2006-06-27 | 2006-08-09 | Univ Gent | Process for preparing a solid dosage form |
WO2008074097A1 (en) * | 2006-12-21 | 2008-06-26 | Alphapharm Pty Ltd | Pharmaceutical compound and composition |
WO2010003078A2 (en) * | 2008-07-03 | 2010-01-07 | Novartis Ag | Melt granulation process |
WO2010136604A1 (en) * | 2009-05-29 | 2010-12-02 | Dsm Ip Assets B.V. | Transfer matrix for transferring a bioactive agent to body tissue |
CN103391769A (zh) | 2011-02-17 | 2013-11-13 | 霍夫曼-拉罗奇有限公司 | 通过热熔挤出使活性药物成分从过冷液体状态受控结晶的方法 |
AU2012308663B2 (en) * | 2011-09-14 | 2017-06-08 | Amgen (Europe) GmbH | Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
JPH054919A (ja) * | 1990-07-25 | 1993-01-14 | Sankyo Co Ltd | チアゾリジン誘導体の固体分散体 |
WO1992018106A1 (en) * | 1991-04-16 | 1992-10-29 | Nippon Shinyaku Co., Ltd. | Method of manufacturing solid dispersion |
ATE157864T1 (de) * | 1991-12-18 | 1997-09-15 | Warner Lambert Co | Verfahren für die herstellung einer festen dispersion |
US5340591A (en) * | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
DE4226753A1 (de) * | 1992-08-13 | 1994-02-17 | Basf Ag | Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen |
JPH07324086A (ja) * | 1994-05-31 | 1995-12-12 | Sankyo Co Ltd | チアゾリジン誘導体の固体分散体または固体分散体製剤 |
DE19515972A1 (de) * | 1995-05-02 | 1996-11-07 | Bayer Ag | Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung |
-
1998
- 1998-07-24 HN HN1998000115A patent/HN1998000115A/es unknown
- 1998-07-29 CA CA002292586A patent/CA2292586C/en not_active Expired - Fee Related
- 1998-07-29 NZ NZ502869A patent/NZ502869A/xx unknown
- 1998-07-29 KR KR1020007001704A patent/KR20010023085A/ko active Search and Examination
- 1998-07-29 EP EP98937241A patent/EP1011640A1/en not_active Withdrawn
- 1998-07-29 WO PCT/US1998/015693 patent/WO1999008660A1/en not_active Application Discontinuation
- 1998-07-29 AU AU86000/98A patent/AU8600098A/en not_active Abandoned
- 1998-07-29 JP JP2000509400A patent/JP2001515029A/ja not_active Abandoned
- 1998-07-29 US US09/284,858 patent/US20010048946A1/en not_active Abandoned
- 1998-07-29 BR BR9811972-9A patent/BR9811972A/pt not_active Application Discontinuation
- 1998-08-19 AR ARP980104098A patent/AR018252A1/es unknown
- 1998-08-20 SV SV1998000104A patent/SV1998000104A/es not_active Application Discontinuation
- 1998-08-20 ZA ZA987551A patent/ZA987551B/xx unknown
- 1998-08-20 PE PE1998000752A patent/PE109599A1/es not_active Application Discontinuation
- 1998-08-20 GT GT199800136A patent/GT199800136A/es unknown
- 1998-08-20 PA PA19988458101A patent/PA8458101A1/es unknown
- 1998-08-20 CO CO98047585A patent/CO4960652A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
HN1998000115A (es) | 1999-06-02 |
GT199800136A (es) | 2000-02-11 |
PE109599A1 (es) | 1999-12-19 |
US20010048946A1 (en) | 2001-12-06 |
CA2292586A1 (en) | 1999-02-25 |
EP1011640A1 (en) | 2000-06-28 |
KR20010023085A (ko) | 2001-03-26 |
JP2001515029A (ja) | 2001-09-18 |
PA8458101A1 (es) | 2001-12-14 |
SV1998000104A (es) | 1999-07-02 |
NZ502869A (en) | 2002-10-25 |
AU8600098A (en) | 1999-03-08 |
CA2292586C (en) | 2006-02-14 |
WO1999008660A1 (en) | 1999-02-25 |
CO4960652A1 (es) | 2000-09-25 |
ZA987551B (en) | 1999-02-23 |
BR9811972A (pt) | 2000-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR018252A1 (es) | Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral. | |
CR7661A (es) | Composicion de comprimido de liberacion sostenida de pramipexol | |
JP2001515029A5 (es) | ||
CO5611097A2 (es) | Tableta farmaceutica | |
WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
AU2155199A (en) | Microparticles for drug delivery across mucosa and the blood-brain barrier | |
MX9300998A (es) | Sistema mejorado de liberacion farmaceutica y metodo para su preparacion. | |
IL129410A (en) | Unit dose, sustained release oral dosage form of an opioid analgesic and a method for the preparation thereof | |
ATE253894T1 (de) | Pharmazeutische suspensionssysteme | |
ATE333265T1 (de) | Oral anzuwendende schnell zerfallende feste darreichungsformen | |
HK1046244B (zh) | 控制釋放與掩蔽味道的口服藥物組合物 | |
MY135852A (en) | Pharmaceutical products | |
AR030862A1 (es) | Formulaciones medicinales en aerosol | |
BR9913626A (pt) | Formulações de ranolazina de liberação contìnua | |
ZA997727B (en) | Pharmaceutical composition for application to mucosa. | |
BR9917012A (pt) | Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral | |
HRP20020091B1 (en) | ?-carboline drug products | |
DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
AU2003238221A1 (en) | Ibuprofen suspension | |
ID28510A (id) | Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 | |
ATE363899T1 (de) | Pharmazeutische zusammensetzungen mit modafinil | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
UY26861A1 (es) | Composición de eletriptan en forma de partículas | |
DE60041691D1 (de) | Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |